Orexo AB
STO:ORX

Watchlist Manager
Orexo AB Logo
Orexo AB
STO:ORX
Watchlist
Price: 14.04 SEK -3.31% Market Closed
Market Cap: 487.3m SEK

Intrinsic Value

The intrinsic value of one ORX stock under the Base Case scenario is 24.91 SEK. Compared to the current market price of 14.04 SEK, Orexo AB is Undervalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ORX Intrinsic Value
24.91 SEK
Undervaluation 44%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Orexo AB

ORX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ORX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Orexo AB
STO:ORX
SE
Pharmaceuticals
Market Cap
483.7m SEK
IPO
Nov 9, 2005
SE
Pharmaceuticals
Market Cap
483.7m SEK
IPO
Nov 9, 2005
Price
krfalse
EPS
krfalse
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ORX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Orexo AB
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Orexo AB

Current Assets 446.4m
Cash & Short-Term Investments 123.3m
Receivables 233.7m
Other Current Assets 89.4m
Non-Current Assets 148.4m
Long-Term Investments 1.6m
PP&E 81.1m
Intangibles 26.9m
Other Non-Current Assets 38.8m
Efficiency

Free Cash Flow Analysis
Orexo AB

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Orexo AB

Revenue
590m SEK
Cost of Revenue
-72.1m SEK
Gross Profit
517.9m SEK
Operating Expenses
-658.2m SEK
Operating Income
-140.3m SEK
Other Expenses
-62.7m SEK
Net Income
-203m SEK
Fundamental Scores

ORX Profitability Score
Profitability Due Diligence

Orexo AB's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional ROE
ROE is Increasing
Positive Revenue Growth Forecast
32/100
Profitability
Score

Orexo AB's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

ORX Solvency Score
Solvency Due Diligence

Orexo AB's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
37/100
Solvency
Score

Orexo AB's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ORX Price Targets Summary
Orexo AB

Wall Street analysts forecast ORX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORX is 40.8 SEK with a low forecast of 40.4 SEK and a high forecast of 42 SEK.

Lowest
Price Target
40.4 SEK
188% Upside
Average
Price Target
40.8 SEK
191% Upside
Highest
Price Target
42 SEK
199% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Orexo AB
does not pay dividends
Shareholder Yield

Current shareholder yield for ORX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ORX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ORX stock?

The intrinsic value of one ORX stock under the Base Case scenario is 24.91 SEK.

Is ORX stock undervalued or overvalued?

Compared to the current market price of 14.04 SEK, Orexo AB is Undervalued by 44%.

Back to Top